The Danish firm’s patents for semaglutide, the active pharmaceutical ingredient in its star brands, will start expiring in ...

It's no secret that GLP-1 medications like Ozempic, Zepbound and Wegovy are helping people achieve amazing health and weight ...

A nurse has tragically died after receiving a weight loss injection in what is believed to be the first confirmed fatality ...

A 58 year old nurse has passed away after receiving a weight loss injection, marking the first reported death linked to the ...

Semaglutide remains on the agency’s drug shortage list, but all FDA-approved forms of the drug are no longer labeled ...

Susan McGowan, 58, died in September after taking two doses of the new generation of weight loss jabs known as GLP-1 agonists ...

The seemingly inexorable rise in global obesity is being reflected in the sales of diabetes and weight-loss drugs, including ...

Losing weight on GLP-1 drugs like Ozempic isn't guaranteed. Experts reveal how to tell if yours isn't working and the next steps you should take to reach your weight loss goals.

Results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in overweight patients with cardiovascular disease.

Recent studies have found that Ozempic could lead to more muscle mass loss than traditional weight loss methods.

A new study published in the New England Journal of Medicine showed that once-weekly injectable semaglutide led to ...

Drugmaker Lupin aims to be part of the first wave of generic drugmakers to make GLP-1 receptor agonists products, used to ...